If you're enrolled in a Medicare Advantage plan, you've almost certainly run into prior authorization — the requirement that your insurer approve certain treatments, procedures, or medications before you can receive them. It's the single most common complaint among Medicare Advantage enrollees, and for good reason: delays in approval can mean delayed surgeries, missed specialist visits, and gaps in post-acute care like skilled nursing or home health services. Now, federal records reveal that a CMS pilot program designed to use artificial intelligence to speed up those approval decisions ran into serious problems during its early rollout — and the details carry real consequences for anyone who depends on timely access to care.
The pilot was built around a straightforward premise: use AI algorithms to process prior authorization requests faster, clearing the backlog that leaves patients waiting days or weeks for decisions on medically necessary care. In theory, AI could instantly flag routine approvals, freeing human reviewers to focus on complex cases. In practice, the federal records indicate the rollout was troubled. Reported problems included inconsistent decision outputs — meaning similar clinical requests were not always processed the same way — inadequate oversight mechanisms, and questions about whether the AI models were being applied appropriately across different patient populations and clinical scenarios. The concern is not that AI was used, but that it was deployed before key technical and accountability questions were resolved.
To understand the stakes, consider the scale of Medicare Advantage. According to CMS.gov data, more than 33 million Americans were enrolled in Medicare Advantage plans as of 2023, representing roughly 51 percent of all Medicare beneficiaries — a share that has grown steadily for a decade. Unlike Original Medicare, which generally does not require prior authorization for medically necessary services covered under Parts A and B, Medicare Advantage plans run by private insurers such as UnitedHealthcare, Humana, Aetna, and Blue Cross Blue Shield affiliates are permitted to require prior authorization as a cost-management tool. That means tens of millions of people face these approval requirements every year, and any systemic flaw in how decisions get made has enormous real-world consequences.
The prior authorization problem was already well-documented before AI entered the picture. A 2023 report from the HHS Office of Inspector General examined Medicare Advantage denials and found that plans were rejecting prior authorization requests that met Medicare's own coverage criteria — in other words, turning away care that beneficiaries were legally entitled to receive. Critically, many of those denials were later overturned on appeal. That pattern tells you something important: the system was already producing errors at scale with human reviewers in the loop. Layering AI into that process without rigorous validation does not fix the underlying problem — it risks amplifying it.
What the federal records appear to show is that CMS moved forward with the AI pilot without fully resolving those validation questions. Among the specific concerns documented: the AI system did not consistently produce the same results when processing clinically similar requests, raising the possibility that two patients with identical diagnoses and treatment needs could receive different authorization outcomes depending on how their request was routed through the system. There were also concerns about whether the AI adequately accounted for clinical nuance — a patient's comorbidities, functional status, or documented history of treatment failures — that experienced human reviewers typically weigh when evaluating whether a particular intervention is medically necessary even if it falls outside a standard protocol.
This is not a hypothetical concern. Post-acute care — skilled nursing facility stays, home health services, inpatient rehabilitation — has been a particular flashpoint. Congressional investigations and investigative reporting have documented cases in which Medicare Advantage insurers used algorithmic tools to systematically cut off post-acute care for elderly patients, often after a fixed number of days regardless of individual clinical need. CMS responded by finalizing new rules in 2024 that require Medicare Advantage plans to ensure prior authorization decisions involve qualified clinical reviewers and that AI tools used in the process meet specific standards — including an explicit prohibition on AI serving as the sole basis for a denial. The troubled rollout of CMS's own pilot suggests that even the agency writing those rules struggled to implement them cleanly.
For beneficiaries, the most important practical takeaway is this: a prior authorization denial is never automatically final, and it is never beyond challenge. Whether the decision was made by a human reviewer, an AI algorithm, or some combination of both, you have the right to appeal. The first step is requesting a written explanation of the denial — your plan is legally required to provide one, and it must specify the clinical or coverage reason for the decision. From there, you can file an internal appeal with the plan. If that appeal fails, you can escalate to an Independent Review Entity, a federally contracted organization that reviews Medicare Advantage disputes independently of the insurance company. If your situation is urgent — meaning a delay could seriously harm your health — you can request an expedited appeal, which requires the plan to respond within 72 hours rather than the standard 14-day window for standard prior authorization requests.
According to CMS.gov data, Medicare Advantage enrollees filed approximately 650,000 appeals in 2021, and plans overturned a significant share of their own initial denials at the internal appeal stage — meaning the first denial was wrong often enough to make appealing well worth the effort. Documenting your situation thoroughly matters: keep copies of your physician's referral or order, any supporting clinical notes, and every piece of written communication from your plan. If your doctor believes the treatment is medically necessary, ask for a letter that says so explicitly and references the relevant clinical guidelines. That documentation strengthens your appeal at every stage.
Data Snapshot: According to CMS.gov data, there were approximately 7,986 Medicare Advantage plan options available nationwide for the 2024 plan year, with an average of roughly 43 plan choices per county. Among those plans, CMS star ratings — which run from 1 to 5 stars — serve as one of the few publicly available proxies for plan quality, including performance on prior authorization and appeals. In 2024, approximately 37 percent of Medicare Advantage enrollees were in plans rated 4 stars or higher, which CMS uses as a threshold for bonus payments and which generally correlates with better performance on member access measures. You can look up your current plan's star rating at Medicare.gov using the Plan Finder tool — it takes about two minutes and gives you a direct basis for comparison during enrollment season.
If prior authorization problems are driving you to consider switching plans, the Annual Enrollment Period — running October 15 through December 7 each year — is your primary window, with new coverage starting January 1. You can also make one plan switch during the Medicare Advantage Open Enrollment Period, which runs January 1 through March 31, with coverage starting the first of the month after you enroll. When comparing plans, go beyond the star rating. Pull up each plan's Evidence of Coverage document — every plan must publish one — and look specifically at the list of services requiring prior authorization. Plans differ substantially: some require authorization for routine specialist visits; others limit it to high-cost procedures and inpatient stays. CMS also publishes annual appeals data by plan, which shows how often a plan's initial denials are overturned. A high overturn rate is a signal that the plan's initial decisions are frequently wrong.
If you're considering leaving Medicare Advantage entirely and returning to Original Medicare, you can do so during either enrollment window above. The trade-off to understand is Medigap coverage. Original Medicare covers roughly 80 percent of approved costs, leaving you responsible for the rest — and without a Medigap policy, those out-of-pocket costs can be substantial. In most states, if you're past your initial Medigap open enrollment period, insurers can use medical underwriting to charge you more or deny coverage based on your health history. However, residents of New York and Connecticut have year-round guaranteed issue rights regardless of health status. About a dozen additional states — including California, Oregon, Nevada, Illinois, Idaho, Louisiana, Maine, Maryland, Missouri, New Jersey, and Oklahoma — have a birthday rule giving you a 30-day window each year around your birthday to switch Medigap plans without underwriting. If you live in one of these states, that window may be your most practical path to changing Medigap coverage without health-based penalties.
The AI prior authorization story is ultimately a story about accountability — specifically, who answers when an algorithm denies a 74-year-old woman her hip replacement or a 79-year-old man his cardiac rehabilitation. The federal records suggest that accountability was not fully worked out before the CMS pilot launched. That gap matters because AI is not going away from healthcare administration — it will become more embedded over time, not less. The question is whether the rules governing its use are strong enough, and enforced rigorously enough, to protect the people whose care hangs in the balance. For now, the most powerful tool available to you is knowledge of your rights: the right to a written denial explanation, the right to appeal, and the right to escalate to an independent reviewer if your plan gets it wrong.
For free, personalized help navigating a prior authorization denial or appeal, contact your State Health Insurance Assistance Program, known as SHIP. SHIP counselors are available in every state, are not affiliated with any insurance company, and provide their services at no cost. You can reach SHIP through 1-800-MEDICARE or at shiphelp.org. For complaints about prior authorization delays or denials that you believe violate CMS rules, you can also file directly with CMS through Medicare.gov. These resources exist because the system is complicated enough that no one should have to navigate it alone.